Contrast Induced Nephropathy (CIN) Completed Phase 4 Trials for Acetylcysteine (DB06151)

Back to Contrast Induced Nephropathy (CIN)

Also known as: Contrast Induced Nephropathy

IndicationStatusPhase
DBCOND0066353 (Contrast Induced Nephropathy (CIN))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00492518Acetylcysteine, Theophylline, and a Combination of Both in the Prophylaxis of Contrast-Induced NephropathyPrevention